Light microscopic autoradiographical localization of drug and neurotransmitter receptors provides investigators with a tool to determine the sites of drug action with a high degree of anatomical resolution. In the cortex, where there is a distinct laminar organization, the differential distribution of receptors can be determined. We have found that differences in the density of specific receptors exist between layers of the cerebral cortex. Our observations include the localization of muscarinic cholinergic, benzodiazepine, opiate, neurotensin, histamine-H l , alphaadrenergic, beta-adrenergic, and high-affinity GABA receptors in the cerebral cortex. Of this list of neurotransmitters only significant concentrations of benzodiazepine, GABA, and beta-adrenergic receptors were found in the cerebellar cortex. Receptor localizations such as these can be coupled with information from immunohistochemical studies to provide the basis for future experimentation in order to define neurotransmitter-specific pathways in the cerebral and cerebellar cortices.
Introduction
The cerebral cortex can be divided into six layers on the basis of different types and arrangements of cells. Many biochemical studies have indicated the presence of specific neurotransmitter pathways to the cortex. For instance, cholinergic projections to the cortex from the septal area have been hypothesized by measuring the decrease in choline acetyltransferase activity following septal lesions (10) . Other cholinergic projections to the cortex are thought to originate from the medial globus pallidus and substantia innominata; based upon evidence of a reduction in cholinergic neuronal markers in the cortex following kainic acid-induced lesions of these subcortical structures (6) . Histaminergic neurons are thought to send fibers into the cortex from neuronal cell bodies in the midbrain or brainstem, which project through the medial forebrain bundle (24) . Techniques used to demonstrate pathways such as those presented above, do not 'Presented in part at the AUTORADIOGRAPHY WORKSHOP on April 11, 1980 , as part of the program at the annual meeting of the Histochemical Society, held in New Orleans, Louisiana, April 11-15, 1980. 'Supported by research grants DA00266 and RSDA award MH00052 (M.j.K.), and postdoctoral fellowships HD05739 (J.K. W.), TW02583 (J.M.P.), and MH07624 (W.S.Y.) provide information concerning the differential distribution of synaptic terminals in the laminae of the cortex.
Immunohistochemical localizations of nerve fibers in the cerebral cortex takes us a step further. These techniques can be used to assign the presence of specific fibers in the different layers of the cortex. Gamma aminobutyric acid (GABA)containing neurons have been localized using antisera prepared against glutamic acid decarboxylase (GAD), the enzyme responsible for GABA synthesis. This neurotransmitter seems to be present in all of the laminae of the cerebral cortex and is thought to be contained in intrinsic neurons (19) . Immunohistochemical localization of neurotensin-containing fibers has verified the presence of this neurotransmitter in the cerebral cortex, but little is known about the origin of these fibers (28) . Immunohistochemical studies of enkephalincontaining neurons have demonstrated very few enkephalin neurons in the cerebral cortex (22, 30) . Noradrenergic nerve fibers, however, appear distributed throughout the cerebral cortex, originating from neuronal cell bodies in the locus ceruleus (4, 14) . Thus, immunohistochemical methods can be used to define laminae where specific neurotransmitter neurons reside, but scanty information is available about where these neurons are actually terminating.
The same controversies exist in regard to neurotransmitter receptor distributions in the cerebellar cortex. For instance, noradrenergic fibers are known to be present in both the The section is photographed using dark field illumination so that the autoradiographic grains appear white on the cover slip. The tissue itself is not visible, since it is slightly below this plane of focus. This photomicrograph indicates total binding and thus any difference noted between B and A can be considered specific QNB binding. (C) By keeping the microscope stage stationary and switching to bright field illumination we can view the tissue section itself as it appears below the autoradiographic image on the cover slip. This photomicrograph represents the tissue as it appears immediately below the autoradiographic grains seen in B. The Roman numerals approximate the six layers of cortex. Note the fairly uniform distribution of QNB binding sites as seen in B in all laminae except layer V. CC = corpus callosum, cp = caudate putamen. Bar = 200 g. granule cell layer and-the molecular layer (13) . Do noradrenergic fibers terminate in both these layers, or are fibers simply passing through the granule cell layer en route to their termination in the molecular layer?
A beneficial adjunct to biochemical and immunohistochemical studies would be the ability to anatomically localize the specific neurotransmitter receptors. Neurophysiological studies have shown that the neurons in the cortex respond to a variety of neurotransmitter agents (9) . Binding studies performed in brain homogenates have demonstrated the presence of many neurotransmitter receptors in the cortex (26), but these studies do not provide any information concerning the differential distribution of receptors within the internal lamination of the cortex.
Our laboratory has been involved in the development of a generally applicable method for the localization of drug and neurotransmitter receptors with diffusible ligands (5, 33) . The technique provides a much greater level of resolution than can be accomplished with other currently available techniques. This article will discuss the use of the autoradiographic method as applicable to the differential localization of neurotransmitter and drug receptors in the cerebral and cerebellar cortices.
Material and Methods
Autoradiographic localization of drug and neurotransmitter receptors is accomplished by labeling the receptor of interest with a radioactive ligand specific for that receptor. This labeling is performed on slide-mounted tissue sections, which are then immersed in buffer to rinse away any nonspecifically bound radioactive ligand. The labeled tissues are then dried, covered with a dry emulsion-coated cover slip and stored, allowing ample time for the radioactive drug to expose the emulsion. Finally the autoradiographic image is developed and the tissue stained, thus providing autoradiographic grains over discernable tissue areas that contain binding sites for the radioactive ligand.
Tissue preparation. We employ brain tissue taken from rats following sacrifice by intracardial perfusion with 0.1% formaldehyde in an isotonic saline solution or phosphate buffered saline. This light fixation slightly improves the quality of the tissue morphology without affecting ligand binding (33) . We have used tissue from the brains of monkeys following intraaortic perfusion with ice cold saline. We have also successfully employed human postmortem tissue, taken at autopsy, which was quickly frozen. These brain tissues are rapidly dissected and placed on brass chucks coated with O.C.T. compound (Lab-Tek Products, Naperville, IL) or brain paste (homogenized animal brains) and frozen by slow immersion in liquid nitrogen. O.C.T. compound is satisfactory for sectioning brain, but with smaller tissues or small parts of tissue (especially those containing large amounts of connective tissue) the brain paste is easier to section and assists in the adherence of the tissue to the slide. Cryostat sections, 4 to 8 microns thick, are picked up on cold chrome-alum/gelatin-coated (subbed) microscope slides. Tissue sections are thaw-mounted on these slides by resting the bottom of the slide on an open skin surface of the sectioner until the tissue "melts" onto the slide. The slide-mounted tissue sections are stored one to several days in the cryostat to allow them to desiccate and more strongly adhere to the subbed slides.
Determination of optimal binding parameters. Slide-mounted
tissue sections are warmed (one at a time) by placement on a slide warmer for a few seconds and then placed in buffer for a preincubation period or directly into the incubation mixture consisting of buffer and radioactive ligand. These solutions are prepared in flasks and transferred to Coplin jars to accommodate immersion of the tissuecontaining side of the slide. Initially the incubation period, temperature and concentration of radioactive ligand are determined from data presented in brain homogenate studies. By using similar binding conditions in our tissue sections we label the receptors and perform a dissociation rate analysis. This procedure is accomplished by rinsing away as much nonspecifically bound radioactivity as possible without forfeiting high specific binding. Triplicate tissue sections (from similar brain areas) are incubated in buffer containing ligand. Under the same conditions, a triplicate set of consecutive slides are incubated in buffer containing the same concentration of radioactive ligand plus an unlabeled substance in such a concentration that the unlabeled substance will displace virtually all of the specific binding to the receptor of interest. The slide-mounted tissue sections are then placed in ice cold buffer alone for varying periods of time. Following this rinsing period, the tissue is wiped from the slide with a Whatman glass microfiber filter disk, which is then placed in a scintillation vial to which 10 ml of Formula-947 (New England Nuclear, Boston, MA) liquid scintillation cocktail is added. The slides are counted in a liquid scintillation counter and the counts per minute of the tissue incubated in the presence of the radioactive ligand (indicating total binding) are compared to the counts from tissue incubated in radioactive ligand plus displacer (indicating nonspecific binding). Subtraction of nonspecific binding from total binding allows formulation of the specific to nonspecific ratios. By comparing these numbers the optimal rinsing time that allows the highest signal to noise ratio can be selected.
Having established the optimal rinse time for our tissue sections we next repeat the experiment using the same concentration of radioactive ligand and displacer, but in this case we vary the incubation time (the amount of time the slide-mounted tissue sections remain in the presence of the radioactive ligand). We now consistently employ the optimal rinse time established in our previous experiment for all subsequent experiments. Variation of the incubation time allows us to study the association rate of the radioactive ligand with its receptor in order to ascertain when equilibrium can be reached. Again by examining the specific to nonspecific ratios we choose the optimal incubation time. Next, in the same way, we perform an experiment in which we vary the concentration of the radioactive ligand, generating a saturation curve. From this experiment we can perform Scatchard analysis of the data and determine the Kd (dissociation constant that indicates affinity). From the Scatchard plot we can also determine the Bmax (number of receptors present) and the presence of a homogeneous or heterogeneous population of binding sites (32) . We also examine Hill plots of the data to determine if there is any cooperativity. An important characteristic to be determined in any binding study is the pharmacological specificity of the receptors. Drug displacement experiments are usually performed with pharmacologically related and unrelated drugs in order to investigate this specificity. We routinely perform displacement curves whereby we optimally label triplicate tissue sections and compare them with sections incubated under the same conditions, but in the presence of varying quantities of displacers. These displacement curves allow us to demonstrate that under our conditions and in our tissue sections we are labeling the receptor as it was originally described in tissue homogenate studies.
Autoradiographic procedures. Slide-mounted tissue sections are obtained as described above and incubated under conditions determined from data presented in previous incubation studies. Following the rinsing period, each slide is dipped quickly in double distilled water to wash away some of the buffer salts. Each slide is then dried, individually, by placing it on a cold plate (a metal pan over ice) and blowing onto the tissue with dried, cooled, and filtered air. The tissue appears dry when examined after 30 sec using this procedure. The slide-mounted tissue sections are placed in plastic slide boxes and kept under the forced airstream from a hair dryer until the box is full of slides. The lid of the box is then taped shut (to keep out moisture) and is stored in a refrigerator until cover slips are applied.
Long flexible cover slips (25 x 77 mm, Corning #0, Corning, NY) are acid cleaned and after drying are dipped (under safelight conditions) in a solution of Kodak NTB-3 photographic emulsion (Rochester, NY) that has been diluted 1 to 1 with double distilled water. The emulsion-coated cover slips are hung on racks for 3 hr to dry and finally stored for 1 to 7 days in opaque plastic containers at 40°C in the presence of Drierite.
When the cover slips and slide-mounted tissue sections have been prepared as described above, both are allowed to come to room temperature before the boxes are opened (to prevent condensation of moisture on the slides or cover slips). Under safelight conditions the dry, emulsion-coated cover slips are glued at one end onto the slides. A small square of Teflon is placed against the cover slip on the tissue end of the slide and the Teflon, cover slip, and slide are clamped tightly together with a binder clip.
These assemblies are placed in light tight containers in the presence of desiccant and kept at 4°C. After an exposure time of weeks to months (depending on the concentration of radioactive drug and its specific activity) the slide assemblies are allowed to come to room temperature before the boxes are opened. Under safelight conditions the binder clip is removed and the flexible cover slip is bent back away from the tissue containing end of the slide. The cover slip is kept away from the tissue by wedging a spacer bar (a small piece of plastic) between the cover slip and slide. The autoradiographic image on the cover slip is then developed. The tissue is next fixed for 10-15 min in Carnoy's Solution (6 parts ethanol to 3 parts chloroform to 1 part glacial acetic acid), rinsed 10 sec in double distilled water and stained with pyronine Y. The slide assemblies are then rinsed several times in double distilled water and allowed to dry on a slide warmer at 40°C. The spacers are then removed and the cover slip reapplied over the tissue-containing end of the slide with Permount mounting fluid (Fisher; Fair Lawn, NJ).
The slides are examined with both bright field and dark field illumination using an Olympus JM microscope (Olympus Optical Co.; New York, NY) for low power magnification. Higher magnification examinations are accomplished with a Leitz Ortholux II (Leitz, West Germany) equipped with a Hinsch Goldman Box (Bunton Instrument Co.; Rockville, MD) for bright field and dark field illumination. Grain counts are performed using a Zeiss Standard Microscope (Zeiss, West Germany) equipped with a grid-containing eyepiece. Nuclei are selected under low power objectives and then focused on using x40 or X 100 oil immersion objectives and the grains counted in randomly selected squares of the grid containing eyepiece. Table 1 lists the ligands and the binding parameters that were employed in the various studies from which these cortical examinations were derived. The reader is advised to seek more detailed information concerning the labeling conditions from the references listed within the table. Let it suffice here to state that optimal binding conditions were used for each individual ligand thereby providing very high specific to nonspecific ratios. Also the kinetics of the binding and its pharmacological displacement profile were studied to the extent that it was apparent that we were specifically labeling the receptors as they were originally described in classical pharmacological studies.
Results

Cerebral Cortex
Muscarinic cholinergic receptors were found distributed fairly uniformly throughout the cerebral cortex except for lamina V where a significant reduction in the receptor concentration was found (Figure 1 ). High affinity GABA receptors were also found in all layers but predominately occurred in laminae I-IV with a slight favoring in receptor number in lamina IV ( Figure  2 ). Receptors for neurotensin were consistently found in lamina IV (Figure 3 ) as were histamine-H, receptors (not shown in same area). Opiate binding sites can be seen in Figure 4 to be distributed in laminae IV and I. Benzodiazepine receptors were also identified spread throughout lamina IV and appeared to a lesser extent in lamina VI ( Figure 5 ). Catecholamine receptor distributions were identified in the cerebral cortex (not shown). Alpha-1 receptors were found fairly uniformly spread throughout all layers of the cortex, while alpha-2 receptors were seen to be slightly elevated in the more superficial laminae (I, II, and III). Beta receptors were also elevated in laminae I, II, and III, but appeared to some extent in all layers.
Cerebellar Cortex
The molecular layer of the rat cerebellar cortex displayed 3 times as many benzodiazepine receptors as the granule cell layer, whereas GABA receptors were found to be highest (8 to 1 ratio) in the granule cell layer (Figure 7) . High concentrations of beta receptors were also localized in the granule cell layer of the cerebellum (Figure 8 ) with grains overlapping into the Purkinje cell layer. Very low levels of muscarinic cholinergic, opiate, neurotensin, and histamine-H l binding sites were found in the rat cerebellum.
Discussion
Previous studies using this technique have shown a correlation between the number of binding sites and the autoradiographic grain density (5, 33) . The grain density has also been shown to increase linearly with time and to increase linearly with increasing ligand concentrations. Thus, the grain density can be taken as an indication of the number of binding sites present in any different layer. In fact, the actual number of binding sites (per µ2) can be deduced from these autoradiograms and from the binding studies. Using this technique to examine receptor distribution, we can determine sites of drug and neurotransmitter action in the cerebral cortex. Figure 6 I II Figure 6 . Simplified schematic of the laminar distribution of some major cell types in the cerebral cortex along with some of their more prominent connections. Most of these cell types exist to some X extent in all cell layers of the cortex, but this general drawing is meant to demonstrate where the different cell types are seen most often. To simplify the drawing further many types of interneurons have been left out _ since they occur throughout the cortex. Note that lamina IV is important because the specific thalamic afferents terminate there and because it presents the capability of handling most of the "cross talk" that is thought to take place between the columns of cortical organization. P = pyramidal cell, S 
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shows a very simplified representation of some of the cells present and their connections in the cerebral cortex. By comparing our maps of receptor distributions with the dendritic ramifications and/or terminals present in the different laminae we can now make some preliminary comments on possible neurotransmitter specific connections in the cerebral cortex. Table 2 lists predominant cell types and nerve endings found in the different lamina of the cerebral cortex along with the distribution of cortical receptors. This list, of course, is greatly simplified and is not meant to be all encompassing, but some general indications can be appreciated. As an example, consider the observation that inhibitory interneurons are found in all layers of the cerebral cortex. GABA is thought to be the inhibitory neurotransmitter in interneurons in many systems. If GABA were the neurotransmitter of interneurons in the cortex, as has been suggested by (GAD) immunocytochemistry (19) (20) (21) , we might hypothesize that the receptor density would be elevated in the superficial layers where axodendritic connections are most numerous. Since muscarinic cholinergic receptors are found in all layers of the cerebral cortex we might suspect that acetylcholine is the neurotransmitter of the nonspecific thalamic afferents that supply terminals in all the laminae. Equally possible is the idea that acetylcholine is the neurotransmitter of the pyramidal cells, since the axonal processes of these cells supply collaterals that ramify in all layers of the cortex. Differences do exist in the different lamina as to the affinity the receptors have for muscarinic agonists. Our laboratory has demonstrated a significantly higher percentage of high affinity binding sites in lamina IV of the cerebral cortex (31) . This type of study allows the formulation of future studies to test the validity of any preliminary hypothesis that might be made. For instance, with selective lesions placed in the thalamus or in the contralateral hemisphere we could remove various inputs to the cortex and thus determine the presynaptic binding sites present in individual laminae of the cortex. Other lesion studies followed by autoradiographic localization of receptors could pinpoint postsynaptic components and possibly indicate which cell type contained the specific receptor. Electrophysiological recording following iontophoretic application of a specific neurotransmitter, in areas that we have described to contain the receptors, could also pinpoint which cell type responds to the Figure 7 . Dark field (A, C) and bright field (B, D) photomicrographs demonstrating the differential densities of GABA (A, B) and benzodiazepine (C, D) receptors in the cerebellum. Note the GABA receptors are more concentrated in the granule cell layer while the benzodiazepine receptor density is greater in the molecular layer.
neurotransmitter of interest. Thus, we have a tool that allows us to visualize the receptors in their respective lamina. This type of study coupled with immunohistochemical localization of terminals would also be valuable in attempting to establish neurotransmitter specific connections in the cerebral cortex.
It should be pointed out that the cortical receptor localizations described here were found in rostrai portions of the rat parietal lobe. This area of presumed association cortex was representative of the laminar distribution of each ligand's binding in virtually all other areas of cortex examined. However, there were distinct regional differences in the concentration of receptors in various subdivisions of the cerebral cortex. Most notably, histamine-H l receptors (16) were consistently noted in nuclei relating to the auditory system (cochlear nuclei, nucleus of the trapezoid body, superior olive, nuclei of the lateral lemniscus, inferior colliculus, and medial geniculate body). When we examined area 41 (presumed auditory cortex) of the rat we found, in lamina IV, the densest concentration of histamine-H t receptors seen in the cortex (Figure 9 ). This would be the predominant area of termination of auditory radiations from the medial geniculate body. Lamina IV in areas of association cortex, such as in the parietal and frontal regions, exhibit relatively low numbers of specific thalamic afferents, whereas the concentration of association and commissural fibers is higher (2) . Previous analyses of benzodiazepine receptors in human striate cortex showed a somewhat more complicated distribution than that presented here, with receptors being found in lamina IV as well as a fairly high density in lamina III (34) . Specific afferents from the lateral geniculate body project via the geniculocalcarine tract to lamina IV and some extend into lamina III in this area.
Lamina V contained the lowest concentration of most of the different receptors we analyzed. Lamina VI was usually less dense as well, except in the quantity of muscarinic cholinergic and benzodiazepine receptors. This is understandable, since lamina V and VI basically contain efferent fibers en route to other areas of brain. The fact that lamina VI appears to contain more muscarinic cholinergic receptors than any other type of receptor we have examined seems to point to this area as a prominent focus for future experimentation in order to discern the cholinoceptive cell type and the source of their cholinergic input.
Combinations of lesion studies and receptor studies could also be carried out in the cerebellar cortex. More straightforward results could be expected from such studies, since the neuronal circuitry in the cerebellum is better delineated. The beta receptors in the molecular layer could be mediating the effects of norepinephrine release from neurons originating in Figure 8 . Bright field and dark field low magnification photographic montage of the grain density indicating the presence of beta adrenergic receptors in the molecular layer of the cerebellum. in = molecular layer, p = layer of Purkinje cells, g = granule cell layer, w = white matter. Bar = 500 µ. the locus ceruleus. Evidence for the existence of noradrenergic terminals in the molecular layer of cerebellum has been obtained by immunohistochemical methods (13) and electrophysiological experiments. GABA receptors in the granule cell layer could be on granule cell dendrites receiving inhibitory terminals of the Golgi cells in the cerebellar glomeruli. Previous studies have shown the presence of GAD in the interneurons of the cerebellum (12) . Thus, the small concentration of GABA receptors in the molecular layer could be on Purkinje cell dendrites and result from synaptic interactions with inhibitory stellate cells. Evidence exists that indicates the presence of GABA receptors on Purkinje cell dendrites (12) . Evidence already exists, as well, that the benzodiazepine receptors are on Purkinje cell dendrites (11) . Benzodiazepine receptor localization in the molecular layer of the cerebellar cortex (where the dendritic arborizations of the Purkinje cells reside) supports this hypothesis. Studies with human cerebellum demonstrated the same distribution of GABA receptors described here (18) . However, while the rat cerebellum did not show any significant labeling of benzodiazepine receptors in the granule cell layer, the human cerebellum demonstrated equal concentrations of benzodiazepine receptors in the molecular layer and granule cell layer (34) . Also, the rat cerebellum did not show appreciable grain densities for the localization of histamine-H t receptors, while the human cerebellum demonstrated a slight increase in grain density (over background), indicating the presence of histamine-H t receptors in the molecular layer (16) .
Inputs to the cerebellum could be removed selectively by lesioning the various nuclei of origin (pons, inferior olive, accessory cuneate nucleus, etc.) or more grossly by sectioning either the middle or inferior cerebellar peduncles. In this way presynaptic membranes from various sources could be removed. Postsynaptic receptors could be removed by lesion of the deep cerebellar nuclei or receptor deficits could be characterized in certain strains of mutant mice, such as the "nervous" mouse, that lack Purkinje cells. If the receptors we have demonstrated in the molecular layer are on the dendritic tree of the Purkinje cells, we would expect this localization to be absent in the nervous mice. It is curious to note that the different parts of the cerebellum, i.e., archicerebellum, paleocerebellum and neocerebellum, that are known to have variations in their inputs, did not drastically differ in their concentration of beta, GABA, or benzodiazepine receptors.
Inputs to the various regions of the cerebellum may be using the same neurotransmitter to supply various sorts of information (proprioception, degree of stretch of muscle fibers, balance, etc.). The connections of cells displaying the receptor type would thus be responsible for the differential processing of this information. On the other hand, cells can be "committed" to synthesize receptors with independence of the input "density."
In summary, we have used a new method to describe the receptor distributions in individual layers of the cerebral and cerebellar cortex. These localizations indicate sites of neurotransmitter action in the cortex and provide some clues as to which cell types may receive specific kinds of neurotransmitter terminals. These studies also suggest futher lesion experiments and regions where electrophysiologic methods would prove most beneficial. This receptor localizing tool is yet another approach to aid in the sorting out of the intricate complexity in the cortices.
